Evidence map›Paper›PMID 41040411›Full record

ArticlebioRxiv : the preprint server for biology2025

Structural basis for regulation of Frizzled-4 signaling by the co-receptor Tetraspanin-12.

Alyana J Granados, Payal P Pratap, Kevin Alexander Estrada Alamo, Katherine J Susa

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alyana J GranadosDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.ORCID 0009-0006-1409-2382
Payal P PratapDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.ORCID 0000-0002-7170-6866
Kevin Alexander Estrada AlamoDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.ORCID 0000-0002-3829-357X
Katherine J SusaDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158, USA.ORCID 0000-0003-0077-667X

Funding

Maximizing Opportunities for Research Excellence - Evaluation Training SupplementR25GM056847 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUNCAN, D'ANNE S., SELLO, JASON K · 1998 to 2023
$14.1M
Identifying, Characterizing, and Targeting Regulators of B Cell ActivationDP5OD036136 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine Julia Susa · 2023 to 2026
$1.6M
NIGMS NIH HHS R25 GM056847NIH HHS DP5 OD036136
6 · The paper itself

Abstract

Norrin is an atypical ligand that regulates retinal angiogenesis through the Wnt/β-catenin pathway by triggering heterodimerization of Frizzled-4 (FZD4) with Low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6), leading to downstream β-catenin stabilization. Unlike Wnt ligands, Norrin requires the tetraspanin Tspan12 for signaling amplification, but it is not understood why. Here, we report a 3.4-angstrom structure of Tspan12 in complex with FZD4 determined by cryo-electron microscopy. The structure reveals that FZD4 and Tspan12 form a direct complex in the absence of Norrin, with a contact interface between the lower hinge of FZD4 and the extracellular loops of Tspan12 that enables FZD4 to respond with a more gradual response to a wider range of Norrin concentrations. The transmembrane (TM) domain of Tspan12 is oriented in a tightly packed four-helix bundle and interacts with TM2 of FZD4 to promote trafficking of Tspan12 to the cell surface. The C-D helices of Tspan12, which mediate binding to Norrin, remain exposed while Tspan12 is in complex with FZD4, facilitating higher-affinity Norrin binding. Cell-based assays reveal that Tspan12 and FZD4 remain associated after Norrin recognition, indicating that Tspan12 is a core component of the FZD4-Norrin-LRP5/6 signaling complex. Together, these studies reveal the molecular mechanism underlying Tspan12-FZD4 complex assembly and enhancement of Norrin signaling and suggest new ways to target the FZD4-Tspan12 complex for ocular diseases of hypo- or hyper-vascularization.

Identifiers

PMID41040411
PMCPMC12485846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.